Cystatin C, β-2-microglobulin and β-trace protein in pre-eclampsia

Acta Obstetricia et Gynecologica Scandinavica

Volumn 86, Issue 8, 2007, Pages 921-926

  Kristensen, K ^a   Wide Swensson, D ^a   Schmidt, C ^b   Blirup Jensen, S ^b   Lindstrom V ^a   Strevens, H ^a   Grubb, A ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b AGILENT TECHNOLOGIES   (United States)

Author keywords

Creatinine; Plasma proteins; Pregnancy; Uric acid

Indexed keywords

BETA 2 MICROGLOBULIN; BETA TRACE PROTEIN; CREATININE; CYSTATIN C; PROSTAGLANDIN D SYNTHASE; UNCLASSIFIED DRUG; URATE;

ADULT; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; TURBIDIMETRY; VENOUS BLOOD;

ADULT; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; BLOOD PROTEINS; CASE-CONTROL STUDIES; CYSTATINS; FEMALE; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, THIRD; ROC CURVE;

EID: 34547198263     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340701318133     Document Type: Article

References (26)

1. Lindheimer MD, Cunningham FG. In: Cunningham FG, editor. Chesley's hypertensive disorders in pregnancy, 2nd edn. Appleton & Lange; 1999.
2. Newman MG, Robichaux AG, Stedman CM, Jaekle RK, Fontenot MT, Dotson T, et al. Perinatal outcomes in preeclampsia that is complicated by massive proteinuria. Am J Obstet Gynecol. 2003;188(1):264-8.
3. Lindheimer MD, Umans JG. Explaining and predicting preeclampsia. N Engl J Med. 2006;355(10):1056-8.
4. Brown MA. The physiology of pre-eclampsia. Clin Exp Pharmacol Physiol. 1995;22(11):781-91.
5. Strevens H, Wide-Swensson D, Torffvit O, Grubb A. Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy. Scand J Clin Lab Invest. 2002;62(2):141-7.
6. Roberts JM. Pregnancy-related hypertension. In: Creasy RK, Resnik R. eds. Maternal-fetal medicine: principles and practice, 3rd ed. WB Saunders, Philadelphia, 1994, pp. 804-43.
7. Filler G, Priem F, Lepage N, Sinha P, Vollmer I, Clark H, et al. Beta-trace protein, cystatin C, beta(2)-microglobulin, and creatinine compared for detecting impaired glomerular filtration rates in children. Clin Chem. 2002;48(5):729-36.
8. Kristensen K, Lindström V, Schmidt C, Blirup-Jensen S, Grubb A, Wide-Swensson D, et al. Temporal changes of the plasma levels of cystatin C, beta-trace protein, beta2-microglobulin, urate and creatinine during pregnancy indicate continuous alterations in the renal filtration process. Scand J Clin Lab Invest. 2007 (in press).
9. Saudan PJ, Farrell TJ, Brown MA. Beta2-microglobulin in hypertensive pregnancies. Am J Kidney Dis. 1998;31(2):308-12.
10. Strevens H, Wide-Swensson D, Grubb A. Serum cystatin C is a better marker for preeclampsia than serum creatinine or serum urate. Scand J Clin Lab Invest. 2001;61(7):575-80.
11. Haddad B, Desvaux D, Livingston JC, Barranger E, Paniel BJ, Sibai BM. Failure of serum beta2-microglobulin levels as an early marker of preeclampsia. Am J Obstet Gynecol. 2000;182(3):595-8.
12. Ben-Haroush A, Bardin R, Erman A, Hod M, Chen R, Kaplan B, et al. Beta2-microglobulin and hypertensive complications in pregnant women at risk. Clin Nephrol. 2002;58(6):411-6.
13. Strevens H, Wide-Swensson D, Grubb A, Hansen A, Horn T, Ingemarsson I, et al. Serum cystatin C reflects glomerular endotheliosis in normal, hypertensive and pre-eclamptic pregnancies. BJOG. 2003;110(9):825-30.
14. Gifford RW, August PA, Cunningham G, Green LA, Lindheimer MD, McNellis D, et al. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183(1):S1-S22.
15. The Declaration of Helsinki. World Med J. 1982;29(6):86-8.
16. Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindstrom V, et al. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem. 1994;40(10):1921-6.
17. Priem F, Althaus H, Birnbaum M, Sinha P, Conradt HS, Jung K. Beta-trace protein in serum: a new marker of glomerular filtration rate in the creatinine-blind range. Clin Chem. 1999;45(4):567-8.
18. Town MHGS, Hammer B, Ziegenhorn J. A sensitive colorimetric method for the enzymatic determination of uric acid. J Clin Chem Clin Biochem. 1985;23:591-4.
19. Solberg HE. The theory of reference values Part 5. Statistical treatment of collected reference values. Determination of reference limits. J Clin Chem Clin Biochem. 1983;21(11):749-60.
20. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993;39(4):561-77.
21. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148(3):839-43.
22. Conde-Agudelo A, Villar J, Lindheimer M. World Health Organization systematic review of screening tests for pre-eclampsia. Obstet Gynecol. 2004;104(6):1367-91.
23. Thangaratinam S, Ismail KM, Sharp S, Coomarasamy A, Khan KS. Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review. BJOG. 2006;113(4):369-78.
24. Schuster E, Weppelmann B. Plasma urate measurements and fetal outcome in preeclampsia. Gynecol Obstet Invest. 1981;12(3):162-7.
25. Sagen N, Haram K, Nilsen ST. Serum urate as a predictor of fetal outcome in severe pre-eclampsia. Acta Obstet Gynecol Scand. 1984;63(1):71-5.
26. Many A, Hubel CA, Roberts JM. Hyperuricemia and xanthine oxidase in preeclampsia, revisited. Am J Obstet Gynecol. 1996;174(1 Pt 1):288-91.